News

1/27/2023

Biomarkers Can Help Improve Clinical Trials for Children with Neurodevelopmental Disorders

Sara Jane Webb, University of Washington IDDRC

In the past decade, many large-scale randomized controlled pharmaceutical clinical trials for children with neurodevelopmental disorders have struggled to demonstrate child clinical changes. In a recent study, researchers from University of Washington IDDRC discuss how biomarkers can help improve clinical trials for children with neurodevelopmental disorders.

1/20/2023

SPARK Uncovers Moderate-effect Genes that Cause Autism

A recent study at Baylor College of Medicine and Texas Children's Hospital-one of AUCD's Intellectual and Developmental Disability Research Centers or IDDRCs-used SPARK data to identify a new class of moderate-effect genes that are associated with less likelihood of intellectual disability and may reveal more about autism and brain development.

1/17/2023

Zebrafish Advance as a Model Organism for Fragile X Syndrome

Fragile X Syndrome is the most common inherited form of autism, caused by variants in the FMR1 gene. Scientists have developed animal models of the disorder to better understand the consequences of the genetic mutation and to see if they can intervene. In a recent study in The Journal of Neuroscience, Geoffrey Goodhill, PhD, Professor of Neuroscience and Developmental Biology at Washington University School of Medicine, and his team describe the utility of zebrafish larvae in recapitulating features of Fragile X.